Home

Kristian Humer

CIK 1872280 · Chief Financial Officer · last filed 2025-12-11

Kristian Humer is a Chief Financial Officer who has filed 14 SEC Form 4 insider transactions across 4 companies since 2021. The most recent filing, for FDMT, was dated Dec 11, 2025.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

14

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
FDMT Chief Financial Officer — $10.18 — $0 1 2025-12-11
Sensei Biotherapeutics, Inc. (SNSE) Delisted Director 447 $13.85 $6.2K $0 5 2025-05-23
FHTX Chief Financial Officer — $4.53 — $0 2 2025-01-24
VRDN CFO and CBO — $18.98 — $0 4 2023-02-10

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-12-11 FDMT Grant (A) — $0 EDGAR
2025-05-23 Sensei Biotherapeutics, Inc. (SNSE) Delisted Grant (A) — $0 EDGAR
2025-01-24 FHTX Grant (A) — $0 EDGAR
2024-06-13 Sensei Biotherapeutics, Inc. (SNSE) Delisted Grant (A) — $0 EDGAR
2024-04-17 FHTX Grant (A) — $0 EDGAR
2023-12-12 VRDN Notice (144) −252,600 -$4.33M EDGAR
2023-12-07 VRDN Notice (144) −24,900 -$470.9K EDGAR
2023-07-12 Sensei Biotherapeutics, Inc. (SNSE) Delisted Grant (A) +4,466 $0 EDGAR
2023-02-10 VRDN Grant (A) — $0 EDGAR
2022-06-14 Sensei Biotherapeutics, Inc. (SNSE) Delisted Grant (A) +4,466 $0 EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.